perindopril has been researched along with Diabetic Angiopathies in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.94) | 18.7374 |
| 1990's | 7 (20.59) | 18.2507 |
| 2000's | 16 (47.06) | 29.6817 |
| 2010's | 10 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chalmers, J; Colagiuri, S; Cooper, M; Harrap, S; Mancia, G; Marre, M; Mohammedi, K; Poulter, N; Williams, B; Woodward, M; Zoungas, S | 1 |
| Davis, SN; Konig, M; Lamos, EM; Stein, SA | 1 |
| Blomster, JI; Chalmers, J; Chow, CK; Harrap, S; Hillis, GS; Li, Q; Mancia, G; Neal, B; Patel, A; Poulter, N; Williams, B; Woodward, M; Zoungas, S | 1 |
| Arima, H; Chalmers, J; Cooper, M; Hamet, P; Harrap, S; Hirakawa, Y; Mancia, G; Ninomiya, T; Poulter, N; Woodward, M; Zoungas, S | 1 |
| Chalmers, J; Cooper, M; Grobbee, R; Hirakawa, Y; Jardine, M; Kengne, AP; Matthews, DR; Patel, A; Poulter, N; Woodward, M; Zoungas, S | 1 |
| Chalmers, J; Harrap, S; Li, Q; Marre, M; Mohammedi, K; Patel, A; Woodward, M; Zoungas, S | 1 |
| Barrios, V; Divison, JA; Escobar, C; Medialdea, F | 1 |
| Abadir, E; Chalmers, J; Cooper, M; de Galan, B; Du, X; Hamet, P; Harrap, S; Lip, GY; Ninomiya, T; Patel, A; Pillai, A; Poulter, N; Woodward, M | 1 |
| Bertrand, M; Boersma, E; Brugts, JJ; Chalmers, J; Ferrari, R; Fox, K; MacMahon, S; Ninomiya, T; Remme, WJ; Simoons, ML | 1 |
| Cass, A; Chalmers, J; de Galan, BE; Glasziou, P; Grobbee, D; Hamet, P; Harrap, S; Heller, S; Lisheng, L; MacMahon, S; Mancia, G; Marre, M; Neal, B; Ninomiya, T; Patel, A; Perkovic, V; Pillai, A; Poulter, N; Travert, F; Woodward, M; Zoungas, S | 1 |
| Anderson, C; Chalmers, J; Cooper, M; de Galan, BE; Dufouil, C; Grobbee, DE; Hackett, M; Hamet, P; Heller, SR; Lisheng, L; MacMahon, S; Mancia, G; Neal, B; Pan, CY; Patel, A; Pillai, A; Poulter, N; Travert, F; Woodward, M; Zoungas, S | 1 |
| de la Sierra, A; Ruilope, LM; Waeber, B | 1 |
| Alexander, J; Beller, E; Chalmers, J; Clarke, P; Glasziou, PP; Patel, A; Poulter, N; Rajmokan, M; Woodward, M | 1 |
| Chalmers, J; Heller, S; Januszewicz, A; Joshi, P; Liu, L; Neal, B; Pan, C; Patel, A; Poulter, N; Tandon, N; Woodward, M; Zoungas, S | 1 |
| Hamet, P | 1 |
| Beulens, JW; Chalmers, J; Cooper, ME; Grobbee, DE; Harrap, S; Kengne, AP; Mancia, G; Neal, B; Patel, A; Poulter, N; van der Schouw, YT; van Dieren, S; Woodward, M; Zoungas, S | 1 |
| Bertrand, ME; Daly, CA; Ferrari, R; Fox, KM; Remme, WJ; Simoons, ML | 1 |
| Leiter, LA; Lonn, EM; Strauss, MH; Verma, S | 1 |
| De Simone, C; Famularo, G; Minisola, G; Nicotra, GC | 1 |
| Kinugawa, S | 1 |
| Krzesinski, JM; Scheen, AJ | 1 |
| Dahlof, B; Dobson, J; Gupta, AK; Poulter, NR; Sever, PS; Wedel, H | 1 |
| Bakris, GL; Berkwits, M | 1 |
| Chou, ST; Cooper, ME; Du, HC; Jandeleit, K; Komers, R; Rumble, J | 1 |
| Cooper, ME; Komers, R; Rumble, JR | 1 |
| Acampora, R; Coppola, L; D'Onofrio, F; Giugliano, D; Giunta, R; Marfella, R | 1 |
| Allen, TJ; Cao, Z; Cooper, ME; Gilbert, RE; Jandeleit, K; Rumble, JR | 1 |
| Chen, HC; Jones, M; Kohner, EM; Patel, V; Rassam, SM | 1 |
| Bonney, MA; Celermajer, DS; McCredie, RJ; McFarlane, R; Molyneaux, L; Yue, DK; Zilkens, R | 1 |
| Chiang, YF; Lee, YJ; Tsai, JC | 1 |
| Cooper, ME; Gin, T; Lim-Joon, T; Rumble, JR | 1 |
| Brichard, S; Ketelslegers, JM; Lambert, AE | 1 |
4 review(s) available for perindopril and Diabetic Angiopathies
| Article | Year |
|---|---|
An insight into the recent diabetes trials: what is the best approach to prevent macrovascular and microvascular complications?
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Gliclazide; Glycated Hemoglobin; Humans; Indapamide; Perindopril; United Kingdom | 2013 |
The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Drug Combinations; Humans; Indapamide; Perindopril; Randomized Controlled Trials as Topic | 2009 |
What matters in ADVANCE and ADVANCE-ON.
Topics: Antihypertensive Agents; Biomarkers; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Drug Combinations; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemic Agents; Incidence; Indapamide; Kidney Failure, Chronic; Multicenter Studies as Topic; Perindopril; Randomized Controlled Trials as Topic; Risk Factors | 2012 |
[Diabetic heart disease].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Neuropathies; Heart Failure; Humans; Insulin Resistance; Myocardial Contraction; Myocardial Infarction; Perindopril; Tetrazoles; Ventricular Remodeling | 2007 |
16 trial(s) available for perindopril and Diabetic Angiopathies
| Article | Year |
|---|---|
The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes.
Topics: Aged; Alcohol Drinking; Antihypertensive Agents; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Drug Combinations; Female; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Myocardial Infarction; Perindopril; Retrospective Studies; Risk Reduction Behavior; Stroke | 2014 |
Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial.
Topics: Aged; Aged, 80 and over; Blood Glucose; Cause of Death; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Female; Follow-Up Studies; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Office Visits; Perindopril; Risk Factors | 2014 |
Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diagnostic Techniques, Cardiovascular; Disease Progression; Drug Combinations; Female; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Perindopril; Pulse; Risk Factors; Stroke | 2016 |
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.
Topics: Aged; Antihypertensive Agents; Atrial Fibrillation; Blood Glucose; Confidence Intervals; Diabetic Angiopathies; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Risk Factors; Treatment Outcome | 2009 |
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Drug Therapy, Combination; Female; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Microcirculation; Middle Aged; Perindopril; Placebos | 2009 |
Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis.
Topics: Antihypertensive Agents; Australia; Blood Pressure; Cost-Benefit Analysis; Diabetic Angiopathies; Hospital Costs; Humans; Hypertension; Indapamide; Life Expectancy; Perindopril; Quality of Life | 2010 |
Does glycemic control offer similar benefits among patients with diabetes in different regions of the world? Results from the ADVANCE trial.
Topics: Aged; Asia; Australia; Blood Glucose; Canada; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Europe; Europe, Eastern; Female; Gliclazide; Glycated Hemoglobin; Humans; Indapamide; Male; Middle Aged; New Zealand; Perindopril; Proportional Hazards Models | 2011 |
Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Female; Humans; Hypertension; Indapamide; Male; Odds Ratio; Perindopril; Risk Factors; Treatment Outcome | 2012 |
The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Death, Sudden, Cardiac; Diabetic Angiopathies; Double-Blind Method; Female; Heart Arrest; Humans; Male; Middle Aged; Myocardial Infarction; Perindopril; Prospective Studies | 2005 |
[Clinical trial of the month. ADVANCE: improved survival and better vascular and renal outcomes with a fixed combination of perindopril and indapamide in patients with type 2 diabetes].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diuretics; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Indapamide; Male; Middle Aged; Perindopril; Placebos; Prospective Studies; Survival Rate; Treatment Outcome | 2007 |
Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Diabetic Angiopathies; Drug Therapy, Combination; England; Female; Humans; Hypertension; Male; Middle Aged; Patient Selection; Perindopril; Sweden | 2008 |
Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Blood Pressure; Blood Viscosity; Carbazoles; Carvedilol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Endothelium, Vascular; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Indoles; Leg; Male; Middle Aged; Perindopril; Platelet Aggregation; Propanolamines; Reference Values; Regional Blood Flow; Rheology; Vascular Resistance | 1998 |
Effect of angiotensin-converting enzyme inhibition with perindopril and beta-blockade with atenolol on retinal blood flow in hypertensive diabetic subjects.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Diabetic Angiopathies; Double-Blind Method; Female; Fluorescein Angiography; Hemodynamics; Humans; Hypertension; Indoles; Middle Aged; Perindopril; Regional Blood Flow; Retinal Vessels | 1998 |
Angiotensin converting enzyme inhibition and arterial endothelial function in adults with Type 1 diabetes mellitus.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diuretics; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hydrochlorothiazide; Indoles; Male; Perindopril; Triamterene | 1999 |
Severe nonproductive cough and cough-induced stress urinary incontinence in diabetic postmenopausal women treated with ACE inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cough; Diabetic Angiopathies; Double-Blind Method; Female; Humans; Hypertension; Losartan; Perindopril; Postmenopause; Prevalence; Prospective Studies; Urinary Incontinence, Stress | 2000 |
Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Protocols; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diuretics; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Middle Aged; Multicenter Studies as Topic; Perindopril; Placebos; Randomized Controlled Trials as Topic; Sulfonylurea Compounds | 2001 |
14 other study(ies) available for perindopril and Diabetic Angiopathies
| Article | Year |
|---|---|
Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Female; Gliclazide; Humans; Hypoglycemic Agents; Indapamide; Male; Microvessels; Middle Aged; Perindopril; Risk Factors; Treatment Outcome | 2017 |
Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score.
Topics: Aged; Antihypertensive Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Drug Therapy, Combination; Female; Gliclazide; Health Status Indicators; Humans; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors | 2016 |
Low-dose fixed combination of perindopril plus indapamide in the diabetic hypertensive population.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cross-Sectional Studies; Diabetic Angiopathies; Drug Therapy, Combination; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Perindopril; Treatment Outcome | 2008 |
The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cause of Death; Diabetic Angiopathies; Drug Therapy, Combination; Female; Humans; Indapamide; Male; Middle Aged; Perindopril; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Stroke Volume; Treatment Outcome; Vascular Diseases | 2009 |
Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
Topics: Aged; Antihypertensive Agents; Cognition; Cognition Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Combinations; Drug Therapy, Combination; Educational Status; Female; Gliclazide; Humans; Hypoglycemia; Hypoglycemic Agents; Indapamide; Male; Mental Status Schedule; Myocardial Infarction; Perindopril; Risk Factors; Stroke | 2009 |
Perindopril in diabetes: perspective from the EUROPA substudy, PERSUADE.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Coronary Artery Disease; Diabetic Angiopathies; Humans; Meta-Analysis as Topic; Middle Aged; Myocardial Infarction; Perindopril | 2005 |
Idiosyncratic pancreatitis associated with perindopril.
Topics: Aged; Amylases; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hypertension; Hypoglycemic Agents; Male; Pancreatitis; Perindopril; Treatment Outcome | 2005 |
New drug combo lowers blood pressure: all diabetics benefit. Two drugs offer lifesaving benefits, even in diabetes with normal blood pressure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetic Angiopathies; Diabetic Retinopathy; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril | 2007 |
Trials that matter: the effect of a fixed-dose combination of an Angiotensin-converting enzyme inhibitor and a diuretic on the complications of type 2 diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril | 2008 |
Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hypertrophy; Indoles; Insulin; Male; Muscle, Smooth, Vascular; Perindopril; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Splanchnic Circulation | 1994 |
Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Diabetic Angiopathies; Hypertrophy; Indoles; Kinins; Male; Mesenteric Arteries; Nitric Oxide; Nitroarginine; Perindopril; Rats; Rats, Wistar | 1996 |
Attenuation of diabetes-associated mesenteric vascular hypertrophy with perindopril: morphological and molecular biological studies.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hypertrophy; Indoles; Male; Perindopril; Rats; Rats, Sprague-Dawley; RNA, Messenger; Splanchnic Circulation; Transforming Growth Factor beta | 1998 |
Diabetic renal microvascular disease: the role of hypertension and ACE inhibitors.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Dihydropyridines; Hypertension, Renovascular; Indoles; Kidney Glomerulus; Male; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1992 |
Renal function, glycaemic control and perindopril in diabetic patients.
Topics: Albuminuria; Antihypertensive Agents; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Hypertension; Indoles; Kidney; Middle Aged; Perindopril | 1989 |